{"id":"W4413840783","doi":"10.1016/s0140-6736(25)01682-4","title":"Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials","year":2025,"lang":"en","type":"article","venue":"The Lancet","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"National Heart, Lung, and Blood Institute; Pharmaceuticals Bayer; MSD K.K.; Abbott Vascular; Merck Sharp and Dohme; National Institutes of Health; Bayer; Servier; Pfizer; Moderna; Novo Nordisk; Verily Life Sciences; Bristol-Myers Squibb; Akebia Therapeutics; Agios Pharmaceuticals; Duke Clinical Research Institute; Cytokinetics; Alexion Pharmaceuticals; Eli Lilly and Company; AstraZeneca; Vifor Pharma; Ministero della Salute; Edwards Lifesciences; Amgen; Sanofi; Merck; ZOLL Medical Corporation; Abbott Laboratories; American Heart Association","keywords":"Ejection fraction; Heart failure; Medicine; Fraction (chemistry); Internal medicine; Cardiology; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05660383,0.001373293,0.005561374,0.001185159,0.0006465852,0.00185947,0.001410814,0.002345569,0.004882481],"category_scores_gemma":[0.09975526,0.0007110348,0.01232294,0.002015079,0.0009583749,0.001633846,0.002185545,0.002305706,0.0005183694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001095701,"about_ca_system_score_gemma":0.002267038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001990536,"about_ca_topic_score_gemma":0.004239566,"domain_scores_codex":[0.9223742,0.06047139,0.007491394,0.003879296,0.004675252,0.001108479],"domain_scores_gemma":[0.9461706,0.03287216,0.01142779,0.005391014,0.003253423,0.0008850107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4236261,0.001132038,0.04357801,0.06477202,0.3843282,0.0005687121,0.001270311,0.003431058,0.002257829,0.002789674,0.01604299,0.05620304],"study_design_scores_gemma":[0.3634478,0.04440593,0.1472661,0.01905118,0.3670196,0.001839355,0.00119108,0.005264943,0.001552847,0.007969434,0.04037026,0.000621386],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.628978,0.2220988,0.0248545,0.003933214,0.001341088,0.04603673,0.05754952,0.000379912,0.0148283],"genre_scores_gemma":[0.9277692,0.008753409,0.01302218,0.001686624,0.0003290011,0.0307991,0.01557444,0.0001257041,0.001940345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05660383,"threshold_uncertainty_score":0.2993532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07326057589590726,"score_gpt":0.3653750305060615,"score_spread":0.2921144546101543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}